ASCO® GI 2025 Insights: Ph2 INNOVATION Trial - Outcomes of Perioperative Chemo + Trastuzumab +/- Pertuzumab for 1L HER2+ Gastric/GEJ Cancer | VuMedi

Find latest Gastric Cancer videos · 100+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

This video is featured in the Insights from 2025 ASCO® GI Annual Meeting

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: Ph2 INNOVATION Trial - Outcomes of Perioperative Chemo + Trastuzumab +/- Pertuzumab for 1L HER2+ Gastric/GEJ Cancer

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Anna Dorothea Wagner

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Anna Dorothea Wagner

94 views

March 27, 2025

Comments 0

Login to view comments. Click here to Login